Corneal cross-linking recovery depends on which protocol is performed. Epi-off CXL removes the corneal surface epithelium before riboflavin and UV-A treatment, so the surface must regrow. FDA-approved epi-on Epioxa keeps the epithelium intact and uses a different drug-and-device protocol. Their recovery experiences should not be described as interchangeable.

The purpose of both treatments is to strengthen a cornea affected by keratoconus. The goal is stabilization, not an immediate glasses-free result. Vision can fluctuate while the cornea heals and remodels, even when treatment is progressing normally.

This guide explains the major recovery checkpoints after CXL at Visionary Eye Surgery in Plano. Your protocol-specific instructions and examinations take priority.

Epi-off and epi-on recovery are different

With FDA-approved epi-off iLink/Photrexa treatment, the surgeon removes the epithelium so riboflavin can reach the corneal tissue before UV-A exposure. A bandage contact lens is commonly placed while the surface heals.

With FDA-approved epi-on Epioxa or Epioxa HD, the surface epithelium is not debrided. The treatment uses the O2n System and Boost Goggles with an oxygen-assisted UV-A protocol. Because the surface remains intact, the early discomfort and bandage-lens plan can differ.

Protocol choice depends on age, progression evidence, corneal thickness, surface health, scarring, prior surgery, and the approved indication. It is not simply a choice between a "hard" and "easy" recovery.

The short answer

After epi-off CXL, the first several days usually focus on surface healing, comfort, infection prevention, and monitoring the bandage contact lens. Vision often remains blurry or variable after the surface closes because the cornea continues to remodel.

After epi-on CXL, the early surface-healing phase may be less intensive, but vision, inflammation, and corneal shape still require follow-up. Neither protocol should be evaluated only by how the eye feels on the first day.

Surgery day

Arrange for another adult to drive you home. Vision may be blurry and the eye can be light-sensitive after either protocol.

For epi-off treatment, discomfort may increase as numbing medication wears off because the corneal epithelium has been removed. Use only the medication and comfort plan provided by the surgical team. Do not rub the eye, remove or replace a bandage lens yourself, or use leftover anesthetic drops.

For epi-on treatment, follow the Epioxa-specific medication and protection instructions. Keeping the epithelium intact does not eliminate the need to avoid contamination and attend scheduled examinations.

The first 24 to 72 hours

Early epi-off recovery can include:

Burning, aching, tearing, or a foreign-body sensation.
Light sensitivity.
Blurry or fluctuating vision.
Redness.
Awareness of the bandage contact lens.

The intensity varies. Pain that is severe despite the prescribed plan, increasing rather than improving, or paired with worsening vision needs prompt review.

The surgeon checks the epithelial defect, bandage lens, corneal clarity, inflammation, and signs of infection. If the bandage lens falls out, do not reinsert it. Call the surgical team for instructions.

Epi-on patients may have less surface discomfort, but unexpected pain, vision loss, or marked redness still requires contact with the practice.

Days four through seven

With epi-off CXL, the surface epithelium commonly closes during the first week. The bandage contact lens is removed only after the surgeon confirms that the surface has healed sufficiently. It is not removed according to a calendar alone.

Vision may still be worse than the preoperative baseline or change throughout the day. Surface irregularity, swelling, tear-film instability, and early haze can affect clarity. The fact that the surface is closed does not mean the cornea has finished healing.

Ask before returning to work or driving. Screen tolerance, light sensitivity, reliance on the untreated eye, and job demands vary. Sunglasses can improve comfort outdoors, but they do not replace medical clearance.

Weeks two through four

Discomfort usually becomes less prominent, while visual fluctuation can remain. Continue medication exactly as directed. Steroid-drop plans are individualized and should not be copied from another patient or stopped early without instruction.

During this phase, the team may monitor:

Corneal clarity and haze.
Surface healing and tear-film stability.
Vision and refraction.
Eye pressure when steroid medication is used.
Symptoms that affect school, work, or contact-lens wear.

Specialty contact lenses are not resumed or refit until the cornea and surface are ready. The timing depends on the protocol, healing, and the type of lens.

Months one through six

The cornea continues to remodel after the early surface phase. Vision and prescription can change during this period. New glasses or specialty-lens measurements taken too early may become outdated.

Follow-up topography or tomography is compared with the preoperative baseline to assess shape and stability. Success is not defined by one sharper day. The main question is whether the progressive steepening or thinning that prompted treatment has slowed or stopped over time.

Some patients notice improved optical quality as the cornea stabilizes. Others still need glasses, rigid gas-permeable lenses, or scleral lenses for useful vision. CXL strengthens the cornea; it does not automatically regularize every existing distortion.

When can I exercise, swim, or wear contacts?

There is no single schedule for both protocols and every eye. Ask the surgeon to separate:

Light walking.
Strenuous exercise and heavy lifting.
Swimming, hot tubs, and open water.
Contact sports or activities with eye-trauma risk.
Eye makeup.
Soft, rigid, or scleral contact-lens wear.

For epi-off CXL, the open surface and bandage-lens phase make contamination and eye rubbing especially important. Resume each activity only after the eye has been examined and the surgical team provides clearance.

Warning signs that need an urgent call

Contact the surgical team promptly for:

Sudden or substantial vision loss.
Pain that is severe, worsening, or not controlled by the prescribed plan.
Increasing redness or discharge.
A bandage lens that falls out or becomes sharply painful.
New trauma or chemical exposure.
Symptoms specifically identified as urgent in your postoperative instructions.

Infection and corneal haze are known risks of CXL. Early evaluation matters when symptoms are moving in the wrong direction.

Recovery starts with the right indication

CXL should be connected to evidence of keratoconus or corneal ectasia and a protocol that fits the eye. The FDA Epioxa labeling indicates epi-on treatment for keratoconus in adults and pediatric patients age 13 and older with the specified drug-and-device system. FDA-approved Photrexa/KXL treatment has a separate epi-off indication and protocol.

If you are still deciding whether treatment is needed, read when CXL is considered for keratoconus. For authorization and estimates, use the CXL cost and insurance guide.

Questions to ask before scheduling

Which FDA-approved protocol are you recommending and why?
Will a bandage contact lens be used?
What discomfort plan should I follow?
When will the corneal surface and pressure be checked?
When can I return to school, work, driving, and exercise?
When can specialty contacts be resumed or refit?
How will topography or tomography confirm stability?
Which symptoms require an urgent call?

Start with the Corneal Cross-Linking page or schedule a cornea evaluation at Visionary Eye Surgery in Plano.

Medical sources

Medically Reviewed by Dr. Shehz, DO

Board-Certified Ophthalmologist

Dr. Shehzad Batliwala, DO—better known as Dr. Shehz—is a board-certified ophthalmologist and eye surgeon who brings both technical precision and genuine compassion to every patient he treats.

Explore this content with AI

Open this article in your preferred AI assistant for a plain-English summary, action steps, and questions to ask before booking a consultation.